Skip to content
OpenCapital
Get started

MAZE MAZE Free cash flow margin

Free cash flow margin at other companies

Vertex Pharmaceuticals logo
Vertex PharmaceuticalsVRTX
30.4%+20.2pp
Septerna, Inc. logo
Septerna, Inc.SEPN
467.9%+243pp
Stoke Therapeutics, Inc. logo
Stoke Therapeutics, Inc.STOK
36.2%+18.4pp
Zymeworks logo
ZymeworksZYME
-94.8%+15.5pp
Nurix Therapeutics, Inc. logo
Nurix Therapeutics, Inc.NRIX
-378.7%+24.1pp
Relay Therapeutics, Inc. logo
Relay Therapeutics, Inc.RLAY
-1,536%-429pp

Other financials

Income statement

See full
Revenue$20.0M—
Operating income-$26.6M+25.0%
Net income-$24.2M+26.2%
EPS (diluted)-$0.45+60.9%

Balance sheet

See full
Cash & equivalents$198.8M-32.5%
Total debt$61.2M+137%
Total equity$341.7M+17.0%
Total assets$419.7M+26.1%

Cash flow

See full
Operating cash flow-$39.1M-32.5%
CapEx$93.0K-68.9%
Free cash flow-$39.2M-31.5%

Valuation

See full
Market cap$1.48B—
Enterprise value$1.34B—
P/S7.9×—

Profitability

See full
Operating margin-71.5%—
Net margin-65.4%—

Returns & leverage

See full
Return on equity-38.7%—
Debt / equity0.2×+0.1×
Current ratio17.9×+1.8×